Endonovo Therapeutics (ENDV) Prepaid Assets (2016 - 2023)
Endonovo Therapeutics has reported Prepaid Assets over the past 10 years, most recently at $35504.0 for Q3 2023.
- Quarterly results put Prepaid Assets at $35504.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $35504.0 (changed N/A YoY), and the annual figure for FY2022 was $15724.0, up 97.17%.
- Prepaid Assets for Q3 2023 was $35504.0 at Endonovo Therapeutics, down from $40231.0 in the prior quarter.
- Over the last five years, Prepaid Assets for ENDV hit a ceiling of $81110.0 in Q1 2023 and a floor of $2600.0 in Q3 2020.
- Median Prepaid Assets over the past 5 years was $20725.0 (2021), compared with a mean of $24238.9.
- Biggest five-year swings in Prepaid Assets: plummeted 88.61% in 2022 and later soared 2217.43% in 2023.
- Endonovo Therapeutics' Prepaid Assets stood at $20920.0 in 2019, then soared by 52.13% to $31825.0 in 2020, then plummeted by 74.94% to $7975.0 in 2021, then surged by 97.17% to $15724.0 in 2022, then surged by 125.79% to $35504.0 in 2023.
- The last three reported values for Prepaid Assets were $35504.0 (Q3 2023), $40231.0 (Q2 2023), and $81110.0 (Q1 2023) per Business Quant data.